Caxton Associates (New York)’s Collegium Pharmaceutical COLL Stock Holding History

Caxton Associates (New York)’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$3.07M	Buy
2024 Q2	$1.73M	Buy
2024 Q1	$1.73M	Buy